Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve
Requires Filling Strategic Reserve of Active Drug Ingredients
What it does
Agencies must acquire and store six months of active pharmaceutical ingredients, ready the national reserve, and prefer domestic supplies.
Real-world impact
- Creates a six-month stockpile of drug ingredients for critical medicines.
- Government purchases may encourage more domestic production of drug ingredients.
- Requires planning for a second reserve, affecting government storage and budgets.
Topics
Summary
This order directs the health preparedness office to fill a Strategic Active Pharmaceutical Ingredients Reserve with enough active drug components to make a six-month supply of the Nation's most critical medicines. It requires that the office identify about 26 especially critical drugs, prepare and open the existing repository, purchase needed ingredients (preferring U.S.-made products when possible), and plan for a second repository.
The goal is to protect medicine availability, reduce reliance on foreign suppliers, and encourage domestic manufacturing.
Questions, answered
Ask questions about this executive order and its implications. Try:
- “What agencies are affected by this order?”
- “How does this order change existing policy?”
- “What are the practical implications of this order?”